Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Levocetirizine (2.5mg) + Montelukast (4mg)
Therapeutic Category
General and OTC medicines, Pulmonary, Respiratory, Antihistamines, Pediatrics, Asthma
Dosage Form
Suspension
Packaging Type
With Carton & Measuring Cap
Packaging
60ml
Price
₹99/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Monclip LC Suspension is a combination of Levocetirizine (2.5mg) and Montelukast (4mg), specially formulated for children to provide comprehensive relief from allergic conditions and asthma. This convenient oral suspension is designed to offer effective symptom control, making it easier for parents to manage their child’s allergies and respiratory health.
Levocetirizine, a potent antihistamine, works by blocking histamine, a substance responsible for allergic symptoms such as sneezing, itching, runny nose, and watery eyes. As a second-generation antihistamine, Levocetirizine is less likely to cause drowsiness compared to older antihistamines, making it suitable for children during the day.
Montelukast is a leukotriene receptor antagonist that helps manage asthma by preventing the action of leukotrienes, chemicals involved in airway inflammation. This helps prevent bronchoconstriction, reduce asthma symptoms, and minimize the frequency of asthma attacks.
The combination of these two active ingredients provides dual action by controlling both allergic rhinitis symptoms and asthma, improving the child’s quality of life. The liquid form ensures easy dosage adjustment for children of varying ages and weight, offering a flexible treatment option.
Monclip LC Suspension offers dual therapy, providing both immediate relief from allergy symptoms and long-term management of asthma. This suspension is ideal for children who experience frequent allergic reactions or asthma attacks.
Common side effects may include: Drowsiness or fatigue Dry mouth Headache Stomach upset or diarrhea Serious side effects (rare) may include: Allergic reactions such as rash, swelling, or difficulty breathing Mood swings, irritability, or behavioral changes If side effects persist or worsen, consult a healthcare provider.
Allergic Rhinitis: To relieve symptoms such as sneezing, runny nose, and itchy eyes. Asthma: For the prevention and treatment of asthma, reducing bronchoconstriction and airway inflammation.
Monclip LC Suspension is intended for pediatric use and should be administered under the supervision of a healthcare provider. Not recommended for children under 2 years of age. May cause drowsiness; caution should be exercised when engaging in activities that require full attention. Always follow the prescribed dosage and consult a healthcare provider before altering the dosage.
Store in a cool, dry place, away from direct sunlight (15°C to 25°C). Keep the bottle tightly closed when not in use. Keep out of reach of children.
Composition : Bilastine (10mg/5ml) + Montelukast (4mg/5ml) Suspension
Composition : Bilastine (2.5mg) Suspension
Composition : Fexofenadine HCL I.P. 60mg + Montelukast Sodium I.P. 4mg
Composition : Fexofenadine (30mg/5ml)
Composition : Levocetirizine (2.5mg/5ml)
Composition : Cetirizine (5mg/5ml) Suspension
Composition : Chlorpheniramine Maleate (1mg) + Paracetamol (125mg) + Phenylephrine (5mg)
Composition : Chlorpheniramine Maleate (2mg) + Paracetamol (250mg) + Phenylephrine (5mg)
Composition : Levocetirizine (2.5mg) + Montelukast (4mg) Bilayered
Composition : Levocetirizine (5mg) + Montelukast (10mg) Bilayered
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Levocetirizine + Montelukast Suspension is used for allergic rhinitis, seasonal allergies, bronchial asthma-related symptoms, and respiratory inflammation. It is a strong respiratory, pediatric, and anti-allergic segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from strong demand in pediatric clinics, ENT specialists, general physicians, and respiratory care prescriptions. It is widely prescribed for long-term allergy and asthma control, ensuring steady and repeat business.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for respiratory and anti-allergic formulations with monopoly rights, quality manufacturing standards, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from consistent seasonal demand, pediatric usage, repeat prescriptions, and strong retail movement in allergy and respiratory segments when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this respiratory formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, product availability, and distribution support services.